235 related articles for article (PubMed ID: 21681779)
1. GPRC6A regulates prostate cancer progression.
Pi M; Quarles LD
Prostate; 2012 Mar; 72(4):399-409. PubMed ID: 21681779
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
[TBL] [Abstract][Full Text] [Related]
3. Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.
Ye R; Pi M; Nooh MM; Bahout SW; Quarles LD
Mol Pharmacol; 2019 May; 95(5):563-572. PubMed ID: 30894404
[TBL] [Abstract][Full Text] [Related]
4. Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.
Nesbitt H; Browne G; O'Donovan KM; Byrne NM; Worthington J; McKeown SR; McKenna DJ
J Cell Physiol; 2016 Feb; 231(2):473-82. PubMed ID: 26189652
[TBL] [Abstract][Full Text] [Related]
5. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
[TBL] [Abstract][Full Text] [Related]
6. GPRC6A mediates the non-genomic effects of steroids.
Pi M; Parrill AL; Quarles LD
J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
[TBL] [Abstract][Full Text] [Related]
7. Impaired osteoblast function in GPRC6A null mice.
Pi M; Zhang L; Lei SF; Huang MZ; Zhu W; Zhang J; Shen H; Deng HW; Quarles LD
J Bone Miner Res; 2010 May; 25(5):1092-102. PubMed ID: 19874200
[TBL] [Abstract][Full Text] [Related]
8. GPRC6A: Jack of all metabolism (or master of none).
Pi M; Nishimoto SK; Quarles LD
Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of GPRC6A in prostate cancer metastasis based on case-control and in vitro analyses.
Liu M; Zhao YY; Yang F; Wang JY; Shi XH; Zhu XQ; Xu Y; Wei D; Sun L; Zhang YG; Yang K; Qu YC; Wang X; Liang SY; Chen X; Zhao CX; Zhu L; Tang L; Zheng CG; Yang Z
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2235-48. PubMed ID: 27338047
[TBL] [Abstract][Full Text] [Related]
11. Relaxin promotes prostate cancer progression.
Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
[TBL] [Abstract][Full Text] [Related]
12. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
[TBL] [Abstract][Full Text] [Related]
14. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.
Pi M; Wu Y; Quarles LD
J Bone Miner Res; 2011 Jul; 26(7):1680-3. PubMed ID: 21425331
[TBL] [Abstract][Full Text] [Related]
15. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants.
Rueda P; Harley E; Lu Y; Stewart GD; Fabb S; Diepenhorst N; Cremers B; Rouillon MH; Wehrle I; Geant A; Lamarche G; Leach K; Charman WN; Christopoulos A; Summers RJ; Sexton PM; Langmead CJ
PLoS One; 2016; 11(1):e0146846. PubMed ID: 26785252
[TBL] [Abstract][Full Text] [Related]
16. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice.
Chang SN; Han J; Abdelkader TS; Kim TH; Lee JM; Song J; Kim KS; Park JH; Park JH
Prostate; 2014 Sep; 74(13):1266-77. PubMed ID: 25053105
[TBL] [Abstract][Full Text] [Related]
17. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.
Pi M; Quarles LD
Endocrinology; 2012 May; 153(5):2062-9. PubMed ID: 22374969
[TBL] [Abstract][Full Text] [Related]
18. GPCR6A Is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea.
Pi M; Kapoor K; Ye R; Smith JC; Baudry J; Quarles LD
Mol Nutr Food Res; 2018 Apr; 62(8):e1700770. PubMed ID: 29468843
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of mouse GPRC6A, an L-alpha-amino-acid receptor modulated by divalent cations.
Christiansen B; Hansen KB; Wellendorph P; Bräuner-Osborne H
Br J Pharmacol; 2007 Mar; 150(6):798-807. PubMed ID: 17245368
[TBL] [Abstract][Full Text] [Related]
20. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
Pi M; Nishimoto SK; Darryl Quarles L
Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
